|Last Price||Today's Change||52-Week Range||Trading Volume|
|62.30||1.38 (+2.27%)||46.30 - 64.44||6.6 million (Above Avg)|
Market data as of 4:00PM 03/02/15. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb Announces Dividend
03/02/2015 4:30 PM ET
U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Yervoy® (ipilimumab) as Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence
03/02/2015 9:25 AM ET